Sanofi - Aventis Groupe: Press Release: Nirsevimab: Sanofi, AstraZeneca and Sobi simplify contractual agreements
Nirsevimab: Sanofi, AstraZeneca and Sobi simplify contractual agreements Modification of existing collaboration agreement with AstraZeneca gives Sanofi full commercial control of nirsevimab
Source: finanznachrichten.de